Navigation Links
Novel organic metal hybrids that will revolutionize materials science and chemical engineering
Date:2/18/2008

A novel class of hybrid materials made from metals and organic compounds is changing the face of solid state chemistry and materials science just 10 years after its discovery, with applications already in safe storage of highly inflammable gases such as hydrogen and methane. Europe is aiming to capitalise on core strengths in the field and build critical mass by combining the diverse range of skills required within a coherent research network, following a major workshop organised by the European Science Foundation (ESF).

The materials called MOFs (Metal Organic Frameworks) represent one of the biggest breakthroughs in solid state science whose potential is only just being realised, according to the ESF workshop convenor Grard Frey. The domain is currently exploding, and there are so many potential applications that it is difficult to decide how to prioritise them. The only limit is our imagination, said Frey.

There is no doubt though that the first big application of MOFs - storage of gases - will be highly important, given the urgency of developing alternatives to fossil fuels for automobiles. For hydrogen storage, MOFs are already used, and many carmakers have these products in prototypes, said Frey.

MOFs are porous materials with microscopic sized holes, resembling honeycombs at molecular dimensions. This property of having astronomical numbers of tiny holes within a relatively small volume can be exploited in various ways, one of which is as a repository for gases. Gas molecules diffuse into the MOF solid and are contained within its pores. In the case of gas storage, MOFs offer the crucial advantage of soaking up some of the gas pressure exerted by the molecules. This makes hydrogen derived from non-fossil energy sources such as fuel cells, or even genetically engineered plants, potentially viable as a fuel for cars while the alternative of pressurised canisters is not. The key difference is that the amount of gas stored in a conventional cylinder at say 200 atmospheres pressure could be accommodated in an MOF vessel of the same size at just 30 atmospheres, which is much safer.

The porous nature of MOFs enables them to be exploited in quite another way as catalysts to accelerate chemical reactions for a wide variety of materials production and pharmaceutical applications, although this field, as Frey noted, is still in its infancy. Yet already the field is gaining interest beyond academia from serious companies, with a significant development at the ESF workshop being the presence and support of German chemicals giant BASF. This in turn has provided high endorsement of the fields potential and has stimulated interest from other companies, according to Frey.

But several challenges remain before this potential can be realised, the first one being to assemble research and development teams with the right body of skills. As Frey noted, many of the skills already exist but the researchers need to expand their horizons and focus more broadly on the big picture beyond their specialised domains. There is also the technical challenge of learning first how these materials are formed, and then applying the knowledge to design MOFs matched to specific requirements. MOFs are crystalline solids that form in highly regular patterns from solutions, just as salts and sugars do. Researchers need to learn how to manipulate the starting conditions to obtain just the crystalline composition and arrangement they want.


'/>"/>

Contact: Grard Frey
gferey@wanadoo.fr
33-139-254-359
European Science Foundation
Source:Eurekalert

Related medicine news :

1. Novel mathematical model predicts new wave of drug-resistant HIV infections in San Francisco
2. Novel approach strips staph of virulence
3. UCSD research team identifies novel anticancer drug from the sea
4. Novel compound may lessen heart attack damage
5. Novel molecules developed at UB can boost vaccine potency
6. Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
7. Novel vaccine concept developed by scientists at the Wistar Institute
8. Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
9. Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology
10. Statement by AARP CEO Bill Novelli on President Bushs State of the Union
11. New method enables design, production of extremely novel drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 21, 2017 , ... Hospital M&A activity slowed in the second quarter of ... acquisitions rose to 23 in the second quarter, up 15% from the 20 publicly ... announced deals in the year-ago second quarter. Only four of the transactions disclosed a ...
(Date:7/21/2017)... ... ... The House of Yahweh in Abilene, Texas, has written a new post this week that ... to be more open about positive changes. Yisrayl says the use of force is not ... positive way to solve all; yes, all issues, and he is ready to share this ...
(Date:7/21/2017)... ... ... “Kids aren't born knowing how to regulate their emotions any more than ... St. Louis-based positive education company Generation Mindful. To help with that daunting task, she ... , The kit uses colorful, engaging and educational illustrations and games to teach children ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set of ... FCPX timeline. This effect isolates horizontal and vertical lines of pixels and sorts their ... rotating or flipping animation and can be changed using a drop-down menu. Create amazing ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)... July 11, 2017  Dr. Echenberg, founder of Echenberg Institute, is announcing ... patients who suffer from painful intercourse and other painful pelvic pain conditions ... due to menopause. ... VuVatech LLC ... Sarasota, Florida -based start-up company, VuVatech LLC, fills a ...
(Date:7/10/2017)... -- The tenth annual BioPharm America™ will take ... the Sheraton Boston Hotel, September 26–27. The event will ... makers and innovative biotech startup companies. The event is ... impactful days. BioPharm America is now part of Biotech ... with 4,500+ life science industry influencers participating in 8+ ...
Breaking Medicine Technology: